19-45485728-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005619.5(RTN2):āc.1618T>Cā(p.Ser540Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000328 in 1,613,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_005619.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTN2 | NM_005619.5 | c.1618T>C | p.Ser540Pro | missense_variant | 11/11 | ENST00000245923.9 | NP_005610.1 | |
RTN2 | NM_206900.3 | c.1399T>C | p.Ser467Pro | missense_variant | 10/10 | NP_996783.1 | ||
RTN2 | NM_206901.3 | c.598T>C | p.Ser200Pro | missense_variant | 7/7 | NP_996784.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTN2 | ENST00000245923.9 | c.1618T>C | p.Ser540Pro | missense_variant | 11/11 | 1 | NM_005619.5 | ENSP00000245923 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000520 AC: 13AN: 249854Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135196
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1461808Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 727212
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74278
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2022 | This variant is present in population databases (rs779865623, gnomAD 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The proline amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 841510). This variant has not been reported in the literature in individuals affected with RTN2-related conditions. This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 540 of the RTN2 protein (p.Ser540Pro). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 24, 2021 | - - |
Hereditary spastic paraplegia 12 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein | Nov 28, 2022 | ACMG classification criteria: BP4 supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at